Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

How AI Will Help Brands Transform Packaging Compliance and Speed to Market

RegASK’s AI tool uses machine learning, in partnership with Esko, to deliver clear, up-to-date regulatory information, helping brands keep up with changing rules in different markets.

To address the new and evolving regulations within the industry, and streamline packaging development, RegASK recently partnered with Esko, a global leader in integrated software and hardware solutions for packaging and labeling.
To address the new and evolving regulations within the industry, and streamline packaging development, RegASK recently partnered with Esko, a global leader in integrated software and hardware solutions for packaging and labeling.
Getty Images

Key takeaways:

  • RegASK’s AI-driven platform uses machine learning, specialized large language models, and agentic AI to automate and streamline regulatory tasks.
  • This approach helps global companies across pharmaceuticals, biotech, and cosmetics stay compliant more efficiently by improving accuracy.
  • RegASK’s partnership with Esko connects regulatory intelligence with packaging development tools, enabling design and content compliance.

We all know that life sciences is one of the most tightly regulated industries because its products directly affect human health and safety. These regulations extend beyond product development and manufacturing—they have a significant impact on packaging and labeling as well. Navigating these complex and constantly evolving rules can be challenging. Yet, non-compliance isn’t just inconvenient—it can lead to product recalls, legal penalties, or even harm to patients, making regulatory accuracy critical.

“Compliance with regulations such as the FDA’s labeling requirements, ISO standards for sterile packaging (e.g., ISO 11607), and anti-counterfeiting directives requires extensive documentation, rigorous testing, and careful oversight. Failure to comply can result in severe consequences including product recalls, significant fines, market restrictions, and damage to brand reputation,” says Amen Reghimi, CTO at RegASK, a leading provider of AI-driven regulatory intelligence.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?